Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (3336)	12/16/1997 10:26:00 AM
From: JOHN W.	Read Replies (1) of 6136

Nice move today in VRTX-something defiinitely in the works w/o any news.. Henry, note that you are taking the first shot at me again. I will not respond since you would come back and complain to SI again- and then plead for civility on the threads after you start the initial exchange. After reading the article, it is quite apparent that the failure/resistance to the cocktails is essential for the success of LGND drug. After you stated, you had no interest in the success or failure of AGPH. Why did you not just explain why you were so interested in the resistance issues in the first place. Sneaky like a Fox, Henry. I foundthe connection btwn you-LGND-and Kramer. Enjoy.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next